Press release
Primary Immunodeficiency Market Size is Anticipated to Boosting at a CAGR of ~6 % by 2028 | Transparency Market Research
Primary Immunodeficiency market is estimated to attain a valuation of ~US$ 9.9 Bn by the end of 2028, states a study by Transparency Market Research (TMR). Besides, the report notes that the market is prognosticated to expand at a CAGR of ~6% during the forecast period, 2020-2028
Get a Sample Copy of the Primary Immunodeficiency Market Research Report -https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=3137&utm_source=openpr_amitugare&utm_medium=openpr
The significant players operating in the global Primary Immunodeficiency market are
Shire plc, CSL Behring, Kedrion Biopharma Inc, Grifols, S.A, Octapharma
Key Drivers of the Primary Immunodeficiency Market:
Advances in Genetic Testing and Diagnosis: Improvements in genetic testing technologies, next-generation sequencing (NGS), and molecular diagnostics enable early and accurate diagnosis of PIDs, facilitating personalized treatment approaches and improving patient outcomes.
Increased Awareness and Recognition: Heightened awareness among healthcare providers, patients, and the general public about PIDs contributes to earlier recognition, referral, and management of immune deficiency disorders, reducing diagnostic delays and improving access to care.
Research and Development: Ongoing research efforts focus on elucidating the underlying mechanisms of PIDs, identifying novel genetic mutations, and developing targeted therapies, gene therapies, and immunomodulatory agents to address specific immune defects and improve immune function.
Therapeutic Advances: The development and commercialization of therapeutic interventions for PIDs, including immunoglobulin replacement therapy, hematopoietic stem cell transplantation (HSCT), gene therapy, cytokine therapy, and small molecule inhibitors, offer new treatment options and improved outcomes for patients with primary immunodeficiencies.
Patient Advocacy and Support: Patient advocacy organizations, support groups, and online communities play a vital role in raising awareness, providing education, advocating for access to care, and offering support services for individuals and families affected by PIDs, enhancing quality of life and promoting patient empowerment.
Recent Developments in the Primary Immunodeficiency Market:
Introduction of novel therapeutic modalities for PIDs, including gene therapy approaches, targeted biologics, and small molecule inhibitors, aimed at correcting underlying immune defects, modulating immune function, and preventing infections and complications.
Expansion of newborn screening programs and diagnostic algorithms for PIDs, enabling early identification and intervention in asymptomatic or presymptomatic individuals, reducing the risk of severe infections and long-term complications.
Implementation of precision medicine approaches in the management of PIDs, incorporating genetic testing, immune profiling, and personalized treatment strategies based on individual patient characteristics, immune phenotype, and disease severity.
Integration of digital health technologies, telemedicine platforms, and remote monitoring tools into PID care delivery models to improve access to specialized care, facilitate patient-provider communication, and enhance disease management and treatment adherence.
Collaboration among stakeholders in academia, industry, government agencies, and patient advocacy groups to advance research, clinical trials, and public health initiatives aimed at improving diagnosis, treatment, and outcomes for individuals with primary immunodeficiencies.
Buy this Premium Research Report: - https://www.transparencymarketresearch.com/checkout.php?rep_id=3137<ype=S
Market Segmentation -
Type
Antibody Deficiency
Agammaglobulinaemia
Common Variable Immune Deficiency
Selective IgA Deficiency
IgG Subclass Deficiency
Others
Cellular Deficiency
Ataxia Telangiectasia
Hyper IgM Syndromes
Wiskott-Aldrich Syndrome
DiGeorge Syndrome
Others
Innate Immune
Complement Deficiencies
Hyper IgE Syndrome
Others
End User
Immunoglobuline Replacement Therapy
Antibiotic Therapy
Stem Cell and Gene Therapy
Others (Vaccines, Nutritional Supplements, and Others)
This Report lets you identify the opportunities in Primary Immunodeficiency Market by means of a region:
North America (the United States, Canada, and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, and Southeast Asia (Indonesia, Thailand, Philippines, Malaysia, and Vietnam))
South America (Brazil etc.) The Middle East and Africa (North Africa and GCC Countries)
Key Features of the Primary Immunodeficiency Market Report: -
➤ Analyze competitive developments such as expansions, deployments, new product launches, and market acquisitions.
➤ Examine the market opportunities for stakeholders by identifying higher growth sections.
➤ To study and analyze the global Primary Immunodeficiency industry status and forecast including key regions.
➤ An in-depth analysis of key product segments and application spectrum, providing strategic recommendations to incumbents and new entrants to give them a competitive advantage over others.
➤ It provides a comprehensive analysis of key regions of the industry as well as a SWOT analysis and Porter's Five Forces analysis to provide a deeper understanding of the market.
➤ It helps you make strategic business decisions and investment plans.
More Trending Reports by Transparency Market Research -
Smoking Cessation and Nicotine De Addiction Market: https://www.globenewswire.com/en/news-release/2024/03/11/2843670/32656/en/Smoking-Cessation-and-Nicotine-De-Addiction-Market-to-Reach-USD-27-84-billion-by-2031-at-a-CAGR-of-10-2-Transparency-Market-Research-Inc.html
Dental Suction Mirror Market: https://www.globenewswire.com/en/news-release/2024/03/11/2843924/32656/en/Dental-Suction-Mirror-Market-Poised-to-Grow-to-USD-79-2-million-by-2031-With-a-4-8-CAGR-Exclusive-Report-by-Transparency-Market-Research-Inc.html
About Us Transparency Market Research
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. The firm scrutinizes factors shaping the dynamics of demand in various markets. The insights and perspectives on the markets evaluate opportunities in various segments. The opportunities in the segments based on source, application, demographics, sales channel, and end-use are analysed, which will determine growth in the markets over the next decade.
Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers, made possible by experienced teams of Analysts, Researchers, and Consultants. The proprietary data sources and various tools & techniques we use always reflect the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in all of its business reports.
𝐂𝐨𝐧𝐭𝐚𝐜𝐭 𝐔𝐬
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Primary Immunodeficiency Market Size is Anticipated to Boosting at a CAGR of ~6 % by 2028 | Transparency Market Research here
News-ID: 3431416 • Views: …
More Releases from Transparency Market Research
Global Methanol Market to Reach USD 32.9 Billion by 2034, Growing at 3.4% CAGR | …
The global methanol market was valued at US$ 22.0 billion in 2023 and is expected to witness steady expansion over the next decade. According to industry analysis, the market is projected to grow at a compound annual growth rate (CAGR) of 3.4% from 2024 to 2034, reaching an estimated US$ 32.9 billion by the end of 2034. This growth trajectory reflects the increasing relevance of methanol as a versatile chemical…
Methanol-to-Olefins Market Poised for Sustainable Growth, Set to Reach USD 44.1 …
The global Methanol-to-Olefins (MTO) market is witnessing a strong transformation as industries increasingly shift toward sustainable feedstocks and alternative non-petroleum chemical pathways. Valued at US$ 24.5 billion in 2023, the market is projected to expand at a compound annual growth rate (CAGR) of 5.5% from 2024 to 2034, reaching an estimated US$ 44.1 billion by the end of 2034. This growth trajectory highlights the strategic importance of MTO technology in…
Global Methyl Chloride Market Outlook 2035: Expanding Silicone Demand and Indust …
The global methyl chloride market was valued at US$ 2.2 billion in 2023 and is poised for steady expansion over the coming decade. According to the latest industry outlook, the market is projected to grow at a compound annual growth rate (CAGR) of 5.1% from 2024 to 2035, reaching an estimated US$ 4.1 billion by the end of 2035. This sustained growth reflects the compound's critical role as a chemical…
Global Methyl Ester Sulfonate Market to Reach USD 974.1 Mn by 2031, Driven by Ri …
The global methyl ester sulfonate (MES) market was valued at US$ 656.7 Mn in 2022 and is projected to reach US$ 974.1 Mn by the end of 2031, expanding at a compound annual growth rate (CAGR) of 4.5% from 2023 to 2031. This steady growth trajectory reflects the increasing shift toward biodegradable, plant-based surfactants across personal care, household cleaning, and industrial applications worldwide.
Access an overview of significant conclusions from our…
More Releases for Primary
Premier Primary Care Medicine Recognized as Top-Rated Primary Care Physician in …
Premier Primary Care Medicine has been recognized as the top-rated primary care physician in Marietta, Georgia. The designation highlights the practice's commitment to accessible, high-quality primary care, same-day and next-day appointments, and an approach centered on long-term patient relationships.
Marietta, GA - September 16, 2025 - Premier Primary Care Medicine [https://www.premierpcmed.com/] has been recognized as the top-rated primary care physician in Marietta, Georgia. The designation highlights the practice's commitment to accessible,…
Direct Primary Care Market
Direct Primary Care Market Worth 80.4 Bn 2031- Exclusive Report by InsightAce Analytic Pvt. Ltd.
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Direct Primary Care Market"- By Type (Clinical Services, Telehealth Services, Laboratory Services, Consultative Services), Care Setting (Office-Based DPC Practices, Home-Based DPC Practices, Telehealth-Only DPC Practices, Hybrid DPC Practices), End Users (Individuals, Employers, Small Businesses, Large Corporations, Insurance Companies (offering DPC as…
Primary Sclerosing Cholangitis Market
Primary Sclerosing Cholangitis (PSC) is a rare, chronic liver disease characterized by inflammation and scarring of the bile ducts, leading to liver damage and, ultimately, liver failure. The disease progresses slowly and often goes unnoticed in its early stages. Although the exact cause of PSC remains unknown, it is commonly associated with other inflammatory bowel diseases, particularly ulcerative colitis. The management of PSC includes symptom control, slowing disease progression, and…
Primary Healthcare Conference 2023
3rd World Congress on Primary Healthcare and Medicare Summit
Mercure Roma West, Viale degli Eroi di Cefalonia, 301, 00128 Rome, Italy
Email primaryhealthcare@pulsusgathering.org
On behalf of the Conference Organizing Committee, we would like to invite all of you for the "3rd Word Congress on Primary Healthcare and Medicare", which is going to be held in Rome, Italy on September 21-23, 2023. Primary Healthcare 2023 focuses on the basic theme "To Manifest the Multimorbidity…
Primary Lithium Battery (Primary Lithium Batteries) Market Key Companies and Ana …
The global lithium primary batteries market size will grow from $2.83 billion in 2022 to $2.9 billion in 2023 at a compound annual growth rate (CAGR) of 2.5%
Global " Primary Lithium Battery (Primary Lithium Batteries) Market" 2022 Reports give a Key study on the industry status of the Primary Lithium Battery (Primary Lithium Batteries) Manufacturer with the specific statistics, meaning, definition, SWOT Analysis, expert opinion, and recent development across…
Primary Prevention of Cancer
Primary prevention of cancer aims to prevent the disease before it ever occurs. More than 4 in 10 cancers as well as cancer deaths are linked to modifiable risk factors that can be altered as part of primary cancer prevention. The modifiable risk factors for primary prevention include:
1. Cigarette smoking: Smoking causes almost all cases of lung cancer and accounts for 30% of all cancer deaths. Prevention strategy for this risk…
